microdosing tirzepatide for perimenopause Microdose is changing the conversation around medical weight loss., By starting with a lower dose, some patients may be able to ease into treatment while still receiving support What Is Microdosing Tirzepatide?

In one clinical trial called the Semaglutide Treatment Effect in People with Obesity (STEP) trial, it was found that individuals who took semaglutide lost an average of 15% of their body weight over 68 weeks

The BPC-157 peptide seems to help balance this out by keeping cytokines under control, lowering inflammation without weakening your natural immune response

Flexible Daily Intake Can be combined with a range of complementary nutrients

On the other hand, we also offer non-surgical fat reduction treatments, which are advantageous for those seeking a less invasive option

Your Mobility Changes Are you more inactive because your balance has diminished dramatically